J.A. van Roon

633 citations

19 papers · 420 indexed · h-index 8

Impact in

Rheumatology top 5%
- Systemic Lupus Erythematosus Research
- Rheumatoid Arthritis Research and Therapies
Immunology
- T-cell and B-cell Immunology
- Immune Cell Function and Interaction

Papers in

Rheumatology 10
- Rheumatoid Arthritis Research and Therapies 4
- Osteoarthritis Treatment and Mechanisms 3
- Systemic Lupus Erythematosus Research 3
Physiology 9
- Salivary Gland Disorders and Functions 7

Co-authors: J. W. J. Bijlsma F.P.J.G. Lafeber Willem van Eden Ashley J. Duits Maarten R. Hillen Aike A. Kruize Kyriakos A. Kirou Paul P. Tak
Journals: Annals of the Rheumatic Diseases (11 papers)Osteoarthritis and Cartilage (2 papers)Journal of Translational Medicine (1 paper)Journal of Clinical Investigation (1 paper)RMD Open (1 paper)
Partner nations: Netherlands United States Belgium

In The Last Decade

J.A. van Roon

18 papers receiving 412 citations

Peers

Countries citing papers authored by J.A. van Roon

Since Specialization

Citations

This map shows the geographic impact of J.A. van Roon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J.A. van Roon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J.A. van Roon more than expected).

Fields of papers citing papers by J.A. van Roon

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J.A. van Roon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J.A. van Roon. The network helps show where J.A. van Roon may publish in the future.

Co-authorship network

The 25 scholars most cited alongside J.A. van Roon, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with J.A. van Roon Line = papers co-authored together J.A. van Roon links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

19 of 19 papers shown

#	Work
1	Leflunomide/hydroxychloroquine combination therapy targets type I IFN-associated proteins in patients with Sjögren’s syndrome that show potential to predict and monitor clinical response RMD Open ·Mark Daniel Matlin, Aleksei N. Kost, Ana P. Lopes, Sofie L. M. Blokland, Cornelis P. J. Bekker, Cornelia G van Helden-Meeuwsen, Marjan A. Versnel, Aike A. Kruize, Timothy R. D. J. Radstake, Helen L. Leavis, Maarten R. Hillen, J.A. van Roon	2023	5
2	Development and preliminary validation of the Sjögren's Tool for Assessing Response (STAR): a consensual composite score for assessing treatment effect in primary Sjögren's syndrome Annals of the Rheumatic Diseases ·Raphaèle Séror, Gabriel Baron, Marine Camus, Divi Cornec, Élodie Perrodeau, Simon Bowman, Stefano Bombardieri, Hendrika Bootsma, Jacques‐Eric Gottenberg, Benjamin A. Fisher, Wolfgang Hueber, J.A. van Roon, Valérie Devauchelle‐Pensec, P Gergely, Xavier Mariette, Raphaël Porcher, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown)	2022	42
3	Deciphering the role of cDC2s in Sjögren's syndrome: transcriptomic profile links altered antigen processes with IFN signature and autoimmunity Annals of the Rheumatic Diseases ·Ana P. Lopes, Maarten R. Hillen, Florian Wintermeier, Sofie L. M. Blokland, Cornelis P. J. Bekker, Aridaman Pandit, Aike A. Kruize, Timothy R. D. J. Radstake, J.A. van Roon	2022	13
4	AB0170 Ccr9+ pathogenic thelper cells from primary sjÖgren's syndrome patients are characterised by deregulated pathways associated with effector t cell function Annals of the Rheumatic Diseases ·Sofie L. M. Blokland, Catharina G. K. Wichers, Aridaman Pandit, Roberta Chiesa Bartlemebs, Alfonso Gonzales, J.A. van Roon	2018	1
5	IL4-10 synerkine induces direct and indirect structural cartilage repair in osteoarthritis Osteoarthritis and Cartilage ·Jeremy Rodgers, S.C. Mastbergen, W. A. Cassels, J.A. van Roon, Bovallius, Carl,, F.P. Lafeber	2016	3
6	THU0268 Decreased Expression of MIR-130A and MIR-708 in Type-1 Classical Dendritic Cells of Sjögren's Syndrome Patients Indicates Their Dysregulation Annals of the Rheumatic Diseases ·Maarten R. Hillen, Sofie L. M. Blokland, Eleni Chouri, Ana P. Lopes, Aike A. Kruize, C. Erik Hack, Marzia Rossato, Alfonso Gonzales, J.A. van Roon	2016	1
7	SAT0050 IL4-10 Synerkine Induces Direct and Indirect Structural Cartilage Repair in OA Annals of the Rheumatic Diseases ·Jeremy Rodgers, W. A. Cassels, J.A. van Roon, C. Erik Hack, S.C. Mastbergen, F.P. Lafeber	2015	1
8	Dendritic cells, T-cells and epithelial cells: a crucial interplay in immunopathology of primary Sjögren's syndrome Expert Review of Clinical Immunology ·Maarten R. Hillen, 仲上豪二朗, Aike A. Kruize, J.A. van Roon	2014	37
9	OP0260 Targeting CD1C-Expressing MDCS to Inhibit T Cell Activation and Thymus and Activation Regulated Chemokine (TARC)-Dependent Chemotaxis in RA Annals of the Rheumatic Diseases ·Maarten R. Hillen, Dmitruk Li, F.P. Lafeber, C. Erik Hack, Alfonso Gonzales, J.A. van Roon	2013	2
10	FRI0016 Inhibition of chronic pain by il4-10 synerkine is superior to IL-4 or IL-10 monotherapy: a novel strategy to restrain (inflammatory) pain in rheumatic diseases Annals of the Rheumatic Diseases ·Niels Eijkelkamp, Sarita A. Y. Hartgring, W. A. Cassels, Hanneke L.D.M. Willemen, Qi‐Liang Mao‐Ying, Elizabeth M Freese, Franklin P. Knill, S. Sosio, J.A. van Roon	2013	1
11	FRI0009 Il4-10 synerkine: a novel anti-inflammatory drug to inhibit immunopathology in rheumatic diseases Annals of the Rheumatic Diseases ·Sarita A. Y. Hartgring, Ernest R. Gray, Mok Young Lee, Franklin P. Knill, J.A. van Roon	2013	0
12	Decreased expression of TSLP in labial salivary glands of patients with primary Sjögren’s syndrome is associated with local- and systemic disease parameters Journal of Translational Medicine ·Maarten R. Hillen, A. Bikker, Aike A. Kruize, N. M. Khilnani, Floris P. J. G. Lafeber, C. Erik Hack, Timothy R. D. J. Radstake, J.A. van Roon	2012	1
13	Serum soluble interleukin 7 receptor is strongly associated with lupus nephritis in patients with systemic lupus erythematosus Annals of the Rheumatic Diseases ·Valérie Badot, Moran Feller, J.A. van Roon, Geneviève Depresseux, Selda Aydın, Benoı̂t J. Van den Eynde, Frédéric Houssiau, Bernard Lauwerys	2012	41
14	TSLP: a novel potent proinflammatory mediator that activates myeloid dendritic cells to stimulate Th1 and Th17 activity in rheumatoid arthritis Annals of the Rheumatic Diseases ·Dmitruk Li, C. Erik Hack, Pavel Smirnov, F.P.J.G. Lafeber, J.A. van Roon	2011	2
15	Relationship between the type I interferon signature and the response to rituximab in rheumatoid arthritis patients Arthritis & Rheumatism ·Rogier M. Thurlings, Jessica Bayón Pérez, Janneke Tekstra, J.A. van Roon, Koen Vos, 蘇美珍, Lisa G. M. van Baarsen, Carina L. Bos, Kyriakos A. Kirou, Daniëlle M. Gerlag, Mary K. Crow, J. W. J. Bijlsma, Cornelis L. Verweij, Paul P. Tak	2010	100
16	197 INTERLEUKIN-10 PROTECTS AGAINST BLOOD-INDUCED JOINT DAMAGE Osteoarthritis and Cartilage ·N.W. Jansen, J.A. van Roon, G. Roosendaal, Matthias Theobald, J. W. J. Bijlsma, F.P.J.G. Lafeber	2007	6
17	Interleukin 10 (IL-10), not IL-4 or interferon-gamma production, correlates with progression of joint destruction in rheumatoid arthritis. PubMed ·M. Green, J.A. van Roon, Marieke E. Vianen, J. W. J. Bijlsma, F.P.J.G. Lafeber	2001	24
18	Stimulation of suppressive T cell responses by human but not bacterial 60-kD heat-shock protein in synovial fluid of patients with rheumatoid arthritis. Journal of Clinical Investigation ·J.A. van Roon, Willem van Eden, 林珊, Erlebacher Jd, J. W. J. Bijlsma	1997	76
19	Proinflammatory cytokine production and cartilage damage due to rheumatoid synovial T helper-1 activation is inhibited by interleukin-4. Annals of the Rheumatic Diseases ·J.A. van Roon, 林珊, Ashley J. Duits, F.P.J.G. Lafeber, J. W. J. Bijlsma	1995	64

About J.A. van Roon

J.A. van Roon is a scholar working on Rheumatology, Physiology, Immunology, Pharmacology and Dermatology, having authored 19 papers that have together received 420 indexed citations. Recurring topics across this work include Salivary Gland Disorders and Functions (7 papers), Cytokine Signaling Pathways and Interactions (4 papers), Rheumatoid Arthritis Research and Therapies (4 papers), Osteoarthritis Treatment and Mechanisms (3 papers), Immunotherapy and Immune Responses (3 papers), Systemic Lupus Erythematosus Research (3 papers), Dermatology and Skin Diseases (2 papers) and Diabetes and associated disorders (2 papers). The work is most often cited by research in Rheumatology (188 citations), Immunology (160 citations), Physiology (98 citations), Immunology and Allergy (21 citations) and Oncology (75 citations). J.A. van Roon has collaborated with scholars based in Netherlands, United States and Belgium. Frequent co-authors include J. W. J. Bijlsma, F.P.J.G. Lafeber, Willem van Eden, J. W. J. Bijlsma, Ashley J. Duits, Maarten R. Hillen, Aike A. Kruize, Kyriakos A. Kirou, Paul P. Tak and Carina L. Bos. Their work appears in journals such as Annals of the Rheumatic Diseases, Osteoarthritis and Cartilage, Journal of Translational Medicine, Journal of Clinical Investigation and RMD Open.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact